As long-trusted antibiotics encounter increased resistance by the bacterial pathogens they were originally designed to kill, the need for novel anti-infective drug treatments is mounting. One young company has just raised $2.5 million to continue its work on developing treatments for infectious diseases by using bacterial RNA targets called riboswitches. BioRelix Inc. is building a […]
Fresh off a $12 million fund-raise, sleep services and equipment provider Dormir Inc. has gone shopping, acquiring 15 sleep-therapy centers in the western United States for an undisclosed sum.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
New health investor Excel Venture Management added $4 million to complete the $12 million round for Dormir, the sleep-therapy services and equipment provider. Dormir will use the money for expansion.
Innovation in medical devices. Innovation in vaccines. Even innovation in regulating drug development -- MedCity News saw it all last week.
CHL Medical Partners and Noro-Moseley Partners lead the round. Dormir Chief Executive Tim Miller stated in a press release that the money would be used to support extremely fast growth in its businesses.